Patients With Higher Drug Co-Payments Discouraged From Starting Treatment
Patients newly diagnosed with hypertension, diabetes or high cholesterol are significantly more likely to delay initiating recommended drug treatment if they face higher co-payments for medications, according to a new RAND Corporation study. The delay was significant across all conditions, but the impact was largest among patients who had not previously used prescription drugs, according to the study published in the April 27 edition of the Archives of Internal Medicine.
More: continued here
Filed under: Cholesterol on May 3rd, 2009
You must be logged in to post a comment.